DXCMCommon stockNASDAQ
DXCM Common stock
This is the ticker-level security page. The issuer is Dexcom.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$4.5B
Net income TTM
$720.7M
Total assets
$7.5B
Total debt
Not available
Total equity
$2.7B
Profit margin
16%
ROE
26.4%
ROA
9.6%
Latest issuer financial snapshot: 2024-12-31